 | • レポートコード：MRC2304I0184 • 出版社/出版日：Persistence Market Research / 2023年1月31日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の前臨床CRO市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景・基礎データポイント、主要成功要因、需要分析・予測、価値分析・予測、サービス別（バイオアナリシス・DMPK試験、毒性試験、化合物管理、安全性薬理、その他）分析、エンドユーザー別（バイオ医薬品企業、政府機関・学術機関、医療機器メーカー）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、Eurofins Scientific 、PRA Health Sciences 、Medpace、Pharmaceutical Product Development、Icon Plc、Wuxi Apptec、MPI Researchなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場リスク・動向分析 ・市場背景・基礎データポイント ・主要成功要因 ・需要分析・予測 ・価値分析・予測 ・世界の前臨床CRO市場規模：サービス別 - バイオアナリシス・DMPK試験における市場規模 - 毒性試験における市場規模 - 化合物管理における市場規模 - 安全性薬理における市場規模 - その他サービスにおける市場規模 ・世界の前臨床CRO市場規模：エンドユーザー別 - バイオ医薬品企業における市場規模 - 政府機関・学術機関における市場規模 - 医療機器メーカーにおける市場規模 ・世界の前臨床CRO市場規模：地域別 - 北米の前臨床CRO市場規模 - 中南米の前臨床CRO市場規模 - ヨーロッパの前臨床CRO市場規模 - アジア太平洋の前臨床CRO市場規模 - 中東・アフリカの前臨床CRO市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Global Preclinical CRO Market: Global Industry Analysis 2018-2022 & Opportunity Assessment 2023-2033
A recent market study published by Persistence Market Research on the global Preclinical CRO market offers global industry analysis for 2018-2022 & opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The global Preclinical CRO market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Service Type
Bioanalysis and DMPK studies
In vitro ADME
In-vivo PK
Toxicology Testing
GLP
Non-GLP
Compound Management
Process R&D
Custom Synthesis
Other Compound Managements
Chemistry
Medicinal Chemistry
Computation Chemistry
Safety Pharmacology
Other Service Types
By End-use
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
On-premises
By Region
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Report Chapters
Chapter 01 – Executive Summary
The executive summary of the global Preclinical CRO market includes the global market analysis, proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the global Preclinical CRO market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the global Preclinical CRO market in this chapter, which will help them understand basic information about the global Preclinical CRO market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the global Preclinical CRO market report.
Chapter 03 – Market Background
The associated industry assessment of the global Preclinical CRO market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the global Preclinical CRO market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the market. It offers provides key market dynamics of the global Preclinical CRO market, which include drivers, restraints, and opportunities. Moreover, it will help readers understand key trends followed by leading manufacturers in the global Preclinical CRO market.
Chapter 04 – Global Preclinical CRO Market Analysis 2018-2022 and Forecast, 2023-2033
This section provides detailed analysis of the historical global Preclinical CRO market Value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2022–2023) and an absolute opportunity for the forecast period (2023–2033).
Chapter 05 – Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, by Service Type
Based on components, the global Preclinical CRO market is segmented into (Software Tools: Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Other Service Types). In this chapter, readers can find market attractiveness analysis, based on service type.
Chapter 06 – Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, by End-use
Based on deployment mode, the global Preclinical CRO market is segmented into Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies. In this chapter, readers can find market attractiveness analysis, based on End-use.
Chapter 07 – Global Preclinical CRO Market Analysis 2018-2022 and Opportunity Assessment 2023-2033 by Region
This chapter explains how the global Preclinical CRO market will grow across various geographic regions, such as North America, Latin America, Europe, Asia Pacific and the Middle East and Africa (MEA).
Chapter 08 – North America Global Preclinical CRO Market market Analysis 2018-2022 & Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the global Preclinical CRO market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth based on components, End use, and countries in the North America region.
Chapter 09 – Latin America Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033
Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the global Preclinical CRO market in the Latin America region. This chapter also includes growth prospects of the global Preclinical CRO market in leading LATAM countries such as Brazil and Mexico.
Chapter 10 – Europe Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033
Important growth prospects of the global Preclinical CRO market based on its product type, price, and sales channel in several countries such as Germany, U.K., France, Italy, BENELUX, Nordics, Russia, and Rest of Europe are included in this chapter.
Chapter 11 – Asia Pacific Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the global Preclinical CRO market in the South Asia region, along with a country-wise assessment that includes, China, Japan and South Korea. Readers can also find regional trends, restraints, and market growth of countries in the Asia Pacific region.
Chapter 12 – Middle East and Africa Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033
This chapter offers insights into how the global Preclinical CRO market is expected to grow in major countries in the MEA region such as GCC Countries, South Africa, and the Turkey, during the forecast period 2023-2033.
Chapter 13 – Key Countries Preclinical CRO Market Analysis
This chapter offers insights into how the global Preclinical CRO market is expected to grow in key countries in the such as U.S., Canada, Brazil, Mexico, Germany, U.K., France, Italy, BENELUX, Nordic, Rest of Europe, China, Japan, South Korea, GCC, South Africa, and Turkey during the forecast period 2023-2033.
Chapter 14 – Market Structure Analysis
In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the global Preclinical CRO market along with their market presence analysis by region and product portfolio.
Chapter 15 – Competition Deep-Dive Analysis
In this chapter, readers can find a comprehensive list of manufacturers/ players in the global Preclinical CRO market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the key players in Preclinical CRO market includes Eurofins Scientific, PRA Health Sciences, Medpace, Pharmaceutical Product Development, ICON Plc, Wuxi Apptec, and MPI Research among others.
Chapter 16 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a based to the information and statistics included in the global Preclinical CRO market report.
Chapter 17 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the global Preclinical CRO market.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Preclinical CRO Market (US$ Bn)
4.2. Preclinical CRO Market Opportunity Assessment (US$ Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Preclinical CRO Market Growth
4.5.3. Preclinical CRO Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Preclinical CRO Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Preclinical CRO Market Demand Analysis 2018-2022 and Forecast, 2023-2033
6.1. Historical Market Analysis, 2018-2022
6.2. Current and Future Market Projections, 2023-2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Preclinical CRO Market Value Analysis 2018-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Bn) Analysis, 2018-2022
7.2. Current and Future Market Value (US$ Bn) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By Service Service Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Service Type, 2018-2022
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Service Type, 2023-2033
8.3.1. Bioanalysis and DMPK studies
8.3.1.1. In vitro ADME
8.3.1.2. In-vivo PK
8.3.2. Toxicology Testing
8.3.2.1. GLP
8.3.2.2. Non-GLP
8.3.3. Compund Management
8.3.3.1. Process R&D
8.3.3.2. Custom Synthesis
8.3.3.3. Other Compound Management
8.3.4. Chemistry
8.3.4.1. Medicinal Chemistry
8.3.4.2. Computation Chemistry
8.3.5. Safety Pharmacology
8.3.6. Other Service Types
8.4. Market Attractiveness Analysis By Service Type
9. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By End-use
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By End-use, 2018-2022
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End-use, 2023-2033
9.3.1. Biopharmaceutical Companies
9.3.2. Government and Academic Institutes
9.3.3. Medical Device Companies
9.4. Market Attractiveness Analysis By End-use
10. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Bn) Analysis By Region, 2018-2022
10.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2023-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. APAC
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
11.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Service Type
11.4.3. By End-use
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Service Type
11.5.3. By End-use
12. Latin America Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
12.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Service Type
12.4.3. By End-use
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Service Type
12.5.3. By End-use
13. Europe Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. U.K.
13.4.1.4. Italy
13.4.1.5. Spain
13.4.1.6. Netherlands
13.4.1.7. Rest of Europe
13.4.2. By Service Type
13.4.3. By End-use
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Service Type
13.5.3. By End-use
14. APAC Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of APAC
14.4.2. By Service Type
14.4.3. By End-use
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Service Type
14.5.3. By End-use
15. Middle East and Africa Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
15.4.1. By Country
15.4.1.1. Saudi Arabia
15.4.1.2. South Africa
15.4.1.3. UAE
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Service Type
15.4.3. By End-use
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Service Type
15.5.3. By End-use
16. Key Countries Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Preclinical CRO Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.2.2.1. By Service Type
16.2.2.2. By End-use
16.3. Canada Preclinical CRO Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.3.2.1. By Service Type
16.3.2.2. By End-use
16.4. Mexico Preclinical CRO Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.4.2.1. By Service Type
16.4.2.2. By End-use
16.5. Brazil Preclinical CRO Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.5.2.1. By Service Type
16.5.2.2. By End-use
16.6. Germany Preclinical CRO Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.6.2.1. By Service Type
16.6.2.2. By End-use
16.7. France Preclinical CRO Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.7.2.1. By Service Type
16.7.2.2. By End-use
16.8. Italy Preclinical CRO Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.8.2.1. By Service Type
16.8.2.2. By End-use
16.9. Spain Preclinical CRO Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.9.2.1. By Service Type
16.9.2.2. By End-use
16.10. UK Preclinical CRO Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.10.2.1. By Service Type
16.10.2.2. By End-use
16.11. Netherlands Preclinical CRO Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.11.2.1. By Service Type
16.11.2.2. By End-use
16.12. China Preclinical CRO Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.12.2.1. By Service Type
16.12.2.2. By End-use
16.13. Japan Preclinical CRO Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.13.2.1. By Service Type
16.13.2.2. By End-use
16.14. South Korea Preclinical CRO Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.14.2.1. By Service Type
16.14.2.2. By End-use
16.15. Saudi Arabia Preclinical CRO Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.15.2.1. By Service Type
16.15.2.2. By End-use
16.16. South Africa Preclinical CRO Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.16.2.1. By Service Type
16.16.2.2. By End-use
16.17. UAE Preclinical CRO Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
16.17.2.1. By Service Type
16.17.2.2. By End-use
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Eurofins Scientific
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. PRA Health Sciences
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. Medpace
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. Pharmaceutical Product Development
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. Icon Plc
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
18.3.6. Wuxi Apptec
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Strategy Overview
18.3.7. MPI Research
18.3.7.1. Overview
18.3.7.2. Product Portfolio
18.3.7.3. Sales Footprint
18.3.7.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology